- Home
- ESLA vs HHS Comparison
ESLA vs HHS Comparison
Compare ESLA & HHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESLA
- HHS
- Stock Information
- Founded
- ESLA 2021
- HHS 1923
- Country
- ESLA United States
- HHS United States
- Employees
- ESLA N/A
- HHS N/A
- Industry
- ESLA Biotechnology: Biological Products (No Diagnostic Substances)
- HHS Advertising
- Sector
- ESLA Health Care
- HHS Consumer Discretionary
- Exchange
- ESLA Nasdaq
- HHS Nasdaq
- Market Cap
- ESLA 35.5M
- HHS 30.3M
- IPO Year
- ESLA N/A
- HHS N/A
- Fundamental
- Price
- ESLA $0.86
- HHS $4.03
- Analyst Decision
- ESLA Strong Buy
- HHS
- Analyst Count
- ESLA 1
- HHS 0
- Target Price
- ESLA $16.00
- HHS N/A
- AVG Volume (30 Days)
- ESLA 21.5K
- HHS 31.2K
- Earning Date
- ESLA 08-20-2025
- HHS 08-07-2025
- Dividend Yield
- ESLA N/A
- HHS N/A
- EPS Growth
- ESLA N/A
- HHS N/A
- EPS
- ESLA N/A
- HHS N/A
- Revenue
- ESLA N/A
- HHS $181,355,000.00
- Revenue This Year
- ESLA $101.09
- HHS $6.54
- Revenue Next Year
- ESLA N/A
- HHS N/A
- P/E Ratio
- ESLA N/A
- HHS N/A
- Revenue Growth
- ESLA N/A
- HHS N/A
- 52 Week Low
- ESLA $0.63
- HHS $3.24
- 52 Week High
- ESLA $3.23
- HHS $8.80
- Technical
- Relative Strength Index (RSI)
- ESLA 49.04
- HHS 40.53
- Support Level
- ESLA $0.86
- HHS $3.61
- Resistance Level
- ESLA $0.96
- HHS $4.05
- Average True Range (ATR)
- ESLA 0.09
- HHS 0.57
- MACD
- ESLA -0.00
- HHS 0.01
- Stochastic Oscillator
- ESLA 55.25
- HHS 24.19
About ESLA Estrella Immunopharma Inc.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.
About HHS Harte-Hanks Inc.
Harte-Hanks Inc is a customer experience company. The Company operates three business segments: Marketing Services; Customer Care; and Fulfillment & Logistics Services. The company has a geographic presence in the United States and Other countries. The majority of the revenue is earned from the United States.